Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth
In this weeks edition of InnovationRx, we look at Lillys 2Q earnings, a cannabis-derived drug for PTSD, Apnimeds IPO and more. To get it in your inbox, subscribe here.
Eli Lilly CEO David Ricks
Get…